These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35340120)

  • 1. Oral tranexamic acid with a triple combination cream versus oral tranexamic acid monotherapy in the treatment of severe melasma.
    Martinez-Rico JC; Chavez-Alvarez S; Herz-Ruelas ME; Sosa-Colunga SA; Ocampo-Candiani J; Suro-Santos Y; Vazquez Martinez O
    J Cosmet Dermatol; 2022 Aug; 21(8):3451-3457. PubMed ID: 35340120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
    Basit A; Rahman A; Uddin R
    J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma.
    Del Rosario E; Florez-Pollack S; Zapata L; Hernandez K; Tovar-Garza A; Rodrigues M; Hynan LS; Pandya AG
    J Am Acad Dermatol; 2018 Feb; 78(2):363-369. PubMed ID: 28987494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histological changes in facial melasma after treatment with triple combination cream with or without oral tranexamic acid and/or microneedling: A randomised clinical trial.
    Cassiano DP; Espósito ACC; Hassun KM; Lima MMDA; Lima EVA; Miot LDB; Miot HA; Bagatin E
    Indian J Dermatol Venereol Leprol; 2022; 88(6):761-770. PubMed ID: 35389028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
    Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
    Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of oral tranexamic acid as an adjuvant in Indian patients with melasma: a prospective, interventional, single-centre, triple-blind, randomized, placebo-control, parallel group study.
    Minni K; Poojary S
    J Eur Acad Dermatol Venereol; 2020 Nov; 34(11):2636-2644. PubMed ID: 32567734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Tranexamic Acid with Fluocinolone-Based Triple Combination Cream Versus Fluocinolone-Based Triple Combination Cream Alone in Melasma: An Open Labeled Randomized Comparative Trial.
    Padhi T; Pradhan S
    Indian J Dermatol; 2015; 60(5):520. PubMed ID: 26538719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, open-label study to compare two different dosing regimens of oral tranexamic acid in treatment of moderate to severe facial melasma.
    Bhattacharjee R; Hanumanthu V; Thakur V; Bishnoi A; Vinay K; Kumar A; Parsad D; Kumaran MS
    Arch Dermatol Res; 2023 Aug; 315(6):1831-1836. PubMed ID: 36757440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of tranexamic acid 5% cream vs hydroquinone 4% cream in treating melasma: A split-face comparative clinical, histopathological, and antera 3D camera study.
    El-Husseiny R; Rakha N; Sallam M
    Dermatol Ther; 2020 Nov; 33(6):e14240. PubMed ID: 32856757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical evaluation of efficacy and tolerability of cysteamine 5% cream in comparison with tranexamic acid mesotherapy in subjects with melasma: a single-blind, randomized clinical trial study.
    Karrabi M; Mansournia MA; Sharestanaki E; Abdollahnejad Y; Sahebkar M
    Arch Dermatol Res; 2021 Sep; 313(7):539-547. PubMed ID: 32879998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of fractional erbium:YAG laser-assisted tranexamic acid delivery alone and in combination with oral tranexamic acid in melasma.
    Botsali A; Esme P; Erbil H; Caliskan E
    Lasers Med Sci; 2022 Sep; 37(7):2823-2830. PubMed ID: 35347552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of topical versus intradermal injection of Tranexamic Acid In Egyptian melasma Patients: A randomised clinical trial.
    Badran AY; Ali AU; Gomaa AS
    Australas J Dermatol; 2021 Aug; 62(3):e373-e379. PubMed ID: 33782959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of the combination of tranexamic acid injection and electro-optical synergy (ELOS) versus tranexamic acid injection alone in the treatment of melasma.
    Wang Y; Tang L; Duan J; Wang L; Ye F
    Lasers Med Sci; 2023 Aug; 38(1):179. PubMed ID: 37552377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation.
    Elkamshoushi AM; Romisy D; Omar SS
    J Cosmet Dermatol; 2022 Feb; 21(2):657-668. PubMed ID: 33826785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and safety of 3% tranexamic acid cream vs. 4% hydroquinone cream for mixed-type melasma in skin of color: a double-blind, split-face, randomized controlled trial.
    Yasnova N; Sirait SP; Rahmayunita G
    Acta Dermatovenerol Alp Pannonica Adriat; 2024 Jun; 33(2):83-88. PubMed ID: 38918942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of functional microarray of microneedles combined with topical tranexamic acid for melasma: A randomized, self-controlled, split-face study.
    Xu Y; Ma R; Juliandri J; Wang X; Xu B; Wang D; Lu Y; Zhou B; Luo D
    Medicine (Baltimore); 2017 May; 96(19):e6897. PubMed ID: 28489798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the therapeutic efficacy and safety of combined oral tranexamic acid and topical hydroquinone 4% treatment vs. topical hydroquinone 4% alone in melasma: a parallel-group, assessor- and analyst-blinded, randomized controlled trial with a short-term follow-up.
    Lajevardi V; Ghayoumi A; Abedini R; Hosseini H; Goodarzi A; Akbari Z; Hedayat K
    J Cosmet Dermatol; 2017 Jun; 16(2):235-242. PubMed ID: 27762489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative evaluation of the efficacy of intralesional tranexamic acid versus platelet rich plasma in the treatment of melasma.
    Patil NK; Bubna AK
    Dermatol Ther; 2022 Jul; 35(7):e15534. PubMed ID: 35460158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of therapeutic effects of liposomal Tranexamic Acid and conventional Hydroquinone on melasma.
    Banihashemi M; Zabolinejad N; Jaafari MR; Salehi M; Jabari A
    J Cosmet Dermatol; 2015 Sep; 14(3):174-7. PubMed ID: 26177992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the effect of different doses of oral tranexamic acid on melasma: a multicentre prospective study.
    Zhu CY; Li Y; Sun QN; Takada A; Kawada A
    Eur J Dermatol; 2019 Feb; 29(1):55-58. PubMed ID: 30734717
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.